Expert Opinion on Drug Delivery

Papers
(The TQCC of Expert Opinion on Drug Delivery is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery58
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatmen58
Artificial Intelligence’s role in colon-targeted drug delivery57
Calcium phosphate coated nanoparticles for drug delivery: where are we now?56
How can nanoemulsions be used for photosensitizer drug delivery?54
Iontophoresis for the cutaneous delivery of nanoentraped drugs47
In vivo dermal delivery of bleomycin with electronic pneumatic injection: drug visualization and quantification with mass spectrometry44
Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study43
Brain delivery enabled by transient blood–brain barrier disruption induced by regadenoson: a PET imaging study41
A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement40
The quest to deliver high-dose rifampicin: can the inhaled approach help?40
Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies40
Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs37
Nanominerals: a multifaceted biomaterial for regenerative medicine and drug delivery37
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges37
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug–device combination products: case study of a formative Comparative Use Human Factors study36
Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders34
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years34
Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition34
Self-assembled structures of ascorbic acid derivatives: encapsulation properties and controlled drug delivery applications31
Future applications of self-immolative polymers in drug delivery31
The challenges of drug delivery to the esophagus and how to overcome them31
Current insights into polymeric micelles for nasal drug delivery31
Do the chitosan nanoparticles really augment the drugs’ transdermal fluxes: ending the debate using meta-analysis30
Recent advances in the use of liquid crystalline nanoparticles for non-small cell lung cancer treatment30
Ferulic acid’s therapeutic odyssey: nano formulations, pre-clinical investigations, and patent perspective29
Acetalated dextran: a novel delivery platform for particle-based vaccines29
Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review28
A randomized crossover study assessing critical errors, preferences, and ease of use of two multidose powder inhalers27
Innovative insight into the mechanism of enantioselective skin permeation for chiral drugs27
Progress and potential of nanobubbles for ultrasound-mediated drug delivery26
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice26
Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms26
Current status and prospect for future advancements of long-acting antibody formulations25
Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances25
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson’s disease: is it an improvement on other delivery?25
Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery24
An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery24
Are stimuli-responsive hybrid copolymer nanoparticles the next innovation in tumor drug delivery?23
Novel formulations of metal-organic frameworks for controlled drug delivery23
Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders22
Silica nanoparticles for brain cancer22
Can radiopharmaceuticals be delivered by quantum dots?22
An overview of oral bioavailability enhancement through self-emulsifying drug delivery systems22
Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients21
3D printed dosage forms, where are we headed?21
Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices21
Potential bladder cancer therapeutic delivery systems: a recent update21
Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing21
Current insights into drug-coated balloons for peripheral arterial disease21
A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product20
Intramuscular injection of palmitic acid-conjugated Exendin-4 loaded multivesicular liposomes for long-acting and improving in-situ stability20
Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles20
Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer in vitro and in vivo20
Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application20
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges20
Understanding the interaction forces between shield-triggered autoinjectors and skin: an in-depth noninvasive study20
Untethered shape-changing devices in the gastrointestinal tract19
Targeted transport of biotherapeutics at the blood-brain barrier19
Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development19
Future applications of cyclic antimicrobial peptides in drug delivery19
Platelets for advanced drug delivery in cancer19
Polyphosphoester cubosomes: introducing a novel drug delivery system18
Is electroporation the key to drug delivery in drug-resistant cancers?18
3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives18
Lipid-based nanosystems for wound healing18
Pediatric inhalation therapy and the aerodynamic rationale for age-based aerosol sizes17
An update on cell-penetrating peptides with intracellular organelle targeting17
Recent advances in drug delivery to the central nervous system by inhalation17
Inhalation delivery of nucleic acid gene therapies in preclinical drug development17
Particle surface coating for dry powder inhaler formulations17
Microneedles for oral mucosal delivery – Current trends and perspective on future directions16
Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen16
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier16
Development and approval of novel injectables: enhancing therapeutic innovations16
Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity16
Recent advances in antibacterial nanoformulations for endodontic applications16
Dendrimer-mediated targeting of angiogenic biomarkers: therapeutic intervention against cancer15
Biphasic drug release from electrospun structures15
Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration15
Topical drug delivery to the retina: obstacles and routes to success15
Polymer-based thermoresponsive hydrogels for controlled drug delivery15
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities14
An update on the latest strategies in retinal drug delivery14
Nano-drug delivery system of natural products for disease prevention and treatment14
The impact of common pharmaceutical excipients on the gut microbiota14
Sustained release of brimonidine from conjunctival sac insert to reduce intraocular pressure for glaucoma treatment14
Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier14
Inhaled antifungal therapy: benefits, challenges, and clinical applications14
An evolving perspective on novel modified release drug delivery systems for inhalational therapy14
An interview with professor Dermot O’Toole by Zoe Kenney, commissioning editor14
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery14
Recent developments in nanofiber-based fast-disintegrating drug delivery systems14
Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases14
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids14
Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework14
GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy13
Biodegradable nanoplatforms for antigen delivery: part II – nanoparticles, hydrogels, and microneedles for cancer immunotherapy13
Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy13
The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices13
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I – composition and production methods13
Biopredictive tools for the development of injectable drug products13
Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS13
Advances in plasmonic-based MOF composites, their bio-applications, and perspectives in this field12
Exploring space-energy matching via quantum-molecular mechanics modeling and breakage dynamics-energy dissipation via microhydrodynamic modeling to improve the screening efficiency of nanosuspension p12
Bovine serum albumin nanoparticles: a promising platform for nasal drug delivery12
Solid lipid nanoparticles: a promising tool for insulin delivery12
Breast cancer epidemiology, diagnostic barriers, and contemporary trends in breast nanotheranostics and mechanisms of targeting12
Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines12
Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities12
Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis12
Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations12
Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics12
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance12
Improving antifungal lipid-based drug delivery against Candida : a review12
Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence12
0.11733889579773